[144] Equifax, Incorporated SEC Filing
Equifax (EFX) Form 144 notice reports a proposed sale of 3,000 common shares through Fidelity Brokerage Services with an aggregate market value of $742,050. The shares represent restricted stock that vested and were acquired on 02/23/2024 as compensation from the issuer. The filing shows 123,797,380 shares outstanding and lists an approximate sale date of 08/18/2025 on the NYSE. The filer states there were no securities sold in the past three months and makes the standard representation that they are not aware of any undisclosed material adverse information about the issuer.
Avviso Form 144 di Equifax (EFX) segnala la proposta vendita di 3.000 azioni ordinarie tramite Fidelity Brokerage Services, per un valore complessivo di $742.050. Le azioni sono titoli ristretti che sono diventati maturi e sono stati acquisiti in data 23/02/2024 come compenso dall'emittente. La comunicazione indica 123.797.380 azioni in circolazione e segnala una data indicativa di vendita il 18/08/2025 sulla NYSE. Il dichiarante afferma che non sono stati venduti titoli negli ultimi tre mesi e rilascia la consueta dichiarazione di non essere a conoscenza di informazioni materiali sfavorevoli non divulgate sull'emittente.
Aviso Form 144 de Equifax (EFX) informa sobre la propuesta de venta de 3.000 acciones ordinarias a trav茅s de Fidelity Brokerage Services, con un valor de mercado agregado de $742,050. Las acciones son t铆tulos restringidos que vencieron y fueron adquiridos el 23/02/2024 como compensaci贸n por parte del emisor. La presentaci贸n indica que hay 123.797.380 acciones en circulaci贸n y se帽ala una fecha aproximada de venta el 18/08/2025 en la NYSE. El declarante afirma que no se vendieron valores en los 煤ltimos tres meses y realiza la representaci贸n habitual de no tener conocimiento de informaci贸n material adversa no divulgada sobre el emisor.
Equifax(EFX) Form 144 瓿奠電� Fidelity Brokerage Services毳� 韱淀暣 3,000 氤错喌欤茧ゼ 毵る弰頃� 鞓堨爼鞚措┌, 齑� 鞁滉皜 742,050雼煬霛缄碃 氤搓碃頃╇媹雼�. 頃措嫻 欤检嫕鞚� 鞝滍暅欤茧靹� 2024-02-23鞐� 氤挫儊鞙茧 旆摑頃橃棳 旆摑鞚检棎 甓岆Μ臧� 頇曥爼霅� 欤检嫕鞛呺媹雼�. 鞝滌稖靹滊鞐愲姅 123,797,380欤缄皜 鞙犿喌 欷戩澑 瓴冹溂搿� 旮办灛霅橃柎 鞛堨溂氅�, NYSE鞐愳劀鞚� 鞓堨爼 毵る弰鞚检潉 2025-08-18搿� 響滉赴頃橁碃 鞛堨姷雼堧嫟. 鞁犼碃鞚胳潃 歆�雮� 3臧滌洈臧� 毵る弰頃� 歃濌秾鞚� 鞐嗠嫟瓿� 氚濏瀳氅� 氚滍枆鞚胳棎 甏�頃� 氙戈车臧� 欷戨寑頃� 攵堧Μ頃� 鞝曤炒電� 鞐嗠嫟瓿� 韱奠儊鞝侅溂搿� 歆勳垹頃橁碃 鞛堨姷雼堧嫟.
Avis Form 144 d'Equifax (EFX) signale un projet de vente de 3 000 actions ordinaires via Fidelity Brokerage Services, pour une valeur marchande totale de 742 050 $. Il s'agit d'actions restreintes devenues acquises et obtenues le 23/02/2024 en tant que r茅mun茅ration de l'茅metteur. Le d茅p么t indique 123 797 380 actions en circulation et mentionne une date de vente approximative au 18/08/2025 sur la NYSE. Le d茅clarant affirme qu'aucun titre n'a 茅t茅 vendu au cours des trois derniers mois et fait la repr茅sentation standard de n'avoir connaissance d'aucune information d茅favorable mat茅rielle non divulgu茅e concernant l'茅metteur.
Equifax (EFX) Form 144-Mitteilung meldet einen geplanten Verkauf von 3.000 Stammaktien 眉ber Fidelity Brokerage Services mit einem gesamten Marktwert von $742.050. Die Aktien sind beschr盲nkte Aktien, die am 23.02.2024 als Verg眉tung des Emittenten zugeteilt und freigeworden sind. Die Einreichung weist 123.797.380 ausstehende Aktien aus und nennt den ungef盲hren Verkaufstermin 18.08.2025 an der NYSE. Der Einreicher erkl盲rt, dass in den letzten drei Monaten keine Wertpapiere verkauft wurden, und gibt die 眉bliche Erkl盲rung ab, keine nicht offengelegten, wesentlichen nachteiligen Informationen 眉ber den Emittenten zu kennen.
- Transaction originates from restricted stock vesting, indicating compensation rather than a forced sale
- Small relative size: 3,000 shares equal approximately 0.0024% of outstanding shares, so immaterial to capitalization
- No sales in prior three months, limiting near-term insider selling activity disclosed
- None materially significant disclosed in this filing that would affect investor valuation
Insights
TL;DR Small insider sale notice: 3,000 vested shares for compensation, modest relative size, routine disclosure under Rule 144.
The Form 144 documents a proposed sale of 3,000 common shares valued at $742,050 to be executed via Fidelity on NYSE around 08/18/2025. These shares were acquired through restricted stock vesting on 02/23/2024 and paid as compensation. Relative to the reported 123,797,380 shares outstanding, the proposed sale represents approximately 0.0024% of the outstanding common stock, indicating the transaction is immaterial to overall capitalization. The filer also reports no other sales in the prior three months and affirms no undisclosed material adverse information.
TL;DR Governance-wise this is a routine disclosure tied to compensation vesting and does not signal governance or control changes.
The notice shows the securities originated from restricted stock vesting granted by the issuer, suggesting standard executive or employee compensation mechanics rather than a deliberate divestiture for corporate control reasons. The absence of other sales in the preceding three months and the small size relative to total shares outstanding reduce the likelihood of significant governance implications. The required attestation regarding material information is included.
Avviso Form 144 di Equifax (EFX) segnala la proposta vendita di 3.000 azioni ordinarie tramite Fidelity Brokerage Services, per un valore complessivo di $742.050. Le azioni sono titoli ristretti che sono diventati maturi e sono stati acquisiti in data 23/02/2024 come compenso dall'emittente. La comunicazione indica 123.797.380 azioni in circolazione e segnala una data indicativa di vendita il 18/08/2025 sulla NYSE. Il dichiarante afferma che non sono stati venduti titoli negli ultimi tre mesi e rilascia la consueta dichiarazione di non essere a conoscenza di informazioni materiali sfavorevoli non divulgate sull'emittente.
Aviso Form 144 de Equifax (EFX) informa sobre la propuesta de venta de 3.000 acciones ordinarias a trav茅s de Fidelity Brokerage Services, con un valor de mercado agregado de $742,050. Las acciones son t铆tulos restringidos que vencieron y fueron adquiridos el 23/02/2024 como compensaci贸n por parte del emisor. La presentaci贸n indica que hay 123.797.380 acciones en circulaci贸n y se帽ala una fecha aproximada de venta el 18/08/2025 en la NYSE. El declarante afirma que no se vendieron valores en los 煤ltimos tres meses y realiza la representaci贸n habitual de no tener conocimiento de informaci贸n material adversa no divulgada sobre el emisor.
Equifax(EFX) Form 144 瓿奠電� Fidelity Brokerage Services毳� 韱淀暣 3,000 氤错喌欤茧ゼ 毵る弰頃� 鞓堨爼鞚措┌, 齑� 鞁滉皜 742,050雼煬霛缄碃 氤搓碃頃╇媹雼�. 頃措嫻 欤检嫕鞚� 鞝滍暅欤茧靹� 2024-02-23鞐� 氤挫儊鞙茧 旆摑頃橃棳 旆摑鞚检棎 甓岆Μ臧� 頇曥爼霅� 欤检嫕鞛呺媹雼�. 鞝滌稖靹滊鞐愲姅 123,797,380欤缄皜 鞙犿喌 欷戩澑 瓴冹溂搿� 旮办灛霅橃柎 鞛堨溂氅�, NYSE鞐愳劀鞚� 鞓堨爼 毵る弰鞚检潉 2025-08-18搿� 響滉赴頃橁碃 鞛堨姷雼堧嫟. 鞁犼碃鞚胳潃 歆�雮� 3臧滌洈臧� 毵る弰頃� 歃濌秾鞚� 鞐嗠嫟瓿� 氚濏瀳氅� 氚滍枆鞚胳棎 甏�頃� 氙戈车臧� 欷戨寑頃� 攵堧Μ頃� 鞝曤炒電� 鞐嗠嫟瓿� 韱奠儊鞝侅溂搿� 歆勳垹頃橁碃 鞛堨姷雼堧嫟.
Avis Form 144 d'Equifax (EFX) signale un projet de vente de 3 000 actions ordinaires via Fidelity Brokerage Services, pour une valeur marchande totale de 742 050 $. Il s'agit d'actions restreintes devenues acquises et obtenues le 23/02/2024 en tant que r茅mun茅ration de l'茅metteur. Le d茅p么t indique 123 797 380 actions en circulation et mentionne une date de vente approximative au 18/08/2025 sur la NYSE. Le d茅clarant affirme qu'aucun titre n'a 茅t茅 vendu au cours des trois derniers mois et fait la repr茅sentation standard de n'avoir connaissance d'aucune information d茅favorable mat茅rielle non divulgu茅e concernant l'茅metteur.
Equifax (EFX) Form 144-Mitteilung meldet einen geplanten Verkauf von 3.000 Stammaktien 眉ber Fidelity Brokerage Services mit einem gesamten Marktwert von $742.050. Die Aktien sind beschr盲nkte Aktien, die am 23.02.2024 als Verg眉tung des Emittenten zugeteilt und freigeworden sind. Die Einreichung weist 123.797.380 ausstehende Aktien aus und nennt den ungef盲hren Verkaufstermin 18.08.2025 an der NYSE. Der Einreicher erkl盲rt, dass in den letzten drei Monaten keine Wertpapiere verkauft wurden, und gibt die 眉bliche Erkl盲rung ab, keine nicht offengelegten, wesentlichen nachteiligen Informationen 眉ber den Emittenten zu kennen.
FAQ
What does Equifax's (EFX) Form 144 report?
When is the approximate sale date listed on the Form 144 for EFX?
How material is the proposed sale relative to Equifax's outstanding shares?
Were there any other securities sold by the filer in the past three months?
How were the shares acquired according to the filing?
